Drug intelligence / Profile preview

Oral7

Development stage
Unknown
Lead developer
J.C.E.C. Company
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Oral7 is an immunologically active saliva substitute (IASS) range of oral care products, including mouthwash, spray, gel, and toothpaste, developed to manage xerostomia (dry mouth) and radiation-induced mucositis. The formulation contains a combination of natural enzymes—lactoperoxidase, lysozyme, glucose oxidase, and lactoferrin—which are naturally occurring in human saliva and provide essential antimicrobial and protective functions. By supplementing these enzymes, Oral7 helps restore the oral microenvironment, provides long-lasting moisture, and reduces the risk of oral infections and dental caries. It is particularly indicated for patients undergoing radiotherapy for head and neck cancers (such as nasopharyngeal carcinoma), individuals with Sjögren's syndrome, and those suffering from medication-induced hyposalivation.

Brand names
Oral7Oral-7Oral 7
Other names
Oral7 mouthwashOral-7 mouthwashOral 7 mouthwashOral7 mouth sprayOral-7 mouth sprayOral 7 mouth sprayOral7 gelOral-7 gelOral 7 gelOral7 toothpasteOral-7 toothpasteOral 7 toothpasteOral7 InternationalOral-7 InternationalOral 7 International
02

Targets

PGN (Peptidoglycan)SPS (Salivary peroxidase system)LTF (Lactoferrin)LPO (Lactoperoxidase)LYZ (Lysozyme C)

Beyond the preview

Go deeper on Oral7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call